COO The Cooper Companies, Inc. - Common Stock
NASDAQ · Health Care · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Eyl 9, 2026COO Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
COO Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 20 Şubat 2024 | 4-for-1 | İleri |
| 25 Kasım 2002 | 2-for-1 | İleri |
| 22 Eylül 1995 | 1-for-3 | Ters |
The Cooper Companies, Inc. - Common Stock Hakkında Wikipedia'dan şirket genel bakışı
The Cooper Companies, Inc., branded as CooperCompanies, is a global medical device company headquartered in San Ramon, California. The company consists of two business units, CooperVision (CVI) which manufactures contact lenses, and CooperSurgical (CSI), which manufactures medical devices and fertility and genomic products for the women's healthcare market.
History
Parker Montgomery, a lawyer, bought Martin H. Smith Co. in 1958. The company was renamed to Cooper, Tinsley Laboratories, Inc. in 1961. Its name was changed to Cooper Laboratories Inc. in 1967, and entered the contact lens business when it acquired British lens maker GlobalVision in 1972.
In 1980, Cooper Laboratories reorganized into three business groups: CooperVision, CooperCare and CooperBiomedical, with Cooper Medical Devices Corp. added as a fourth group one year later.
The company was renamed The Cooper Companies in 1987. Three years later, it was further restructured into three business units: CooperVision, CooperSurgical and CooperVision Pharmaceuticals (dissolved in 2003).
Currently, the firm operates as two business units: CooperVision and CooperSurgical. CooperVision serves contact lens wearers and eye care practitioners. Products include a range of daily, two-week and monthly disposable contact lenses, and other spherical, toric and multifocal lenses for astigmatism, nearsightedness and farsightedness, and presbyopia.
CooperSurgical is the medical device and fertility and genomics unit of the companies. It became a business unit in 1990 and its focus includes women's health and fertility. It is headquartered in Trumbull, Connecticut.
Acquisitions
Ocular Sciences Inc. was acquired by CooperVision in 2005.
CooperSurgical acquired AEGEA Medical, a medical manufacturing company in February 2021. A month later, in March, the company acquired Safe Obstetric Systems, and in December 2021, CooperSurgical acquired Generate Life Sciences for $1.6 billion.
In March 2022, CooperSurgical acquired Cook Medical's reproductive health business for $875 million. During that same year the company acquired EnsEyers, a supplier of orthokeratology and scleral contact lenses.
Kaynak: Wikipedia (İngilizce), CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | COO | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | 19.55Y ort. ≈36.1 | ≈36.1 | 28.5 | Düşük değerli | |
| F/S (TTM) | 2.65Y ort. ≈2.5 | ≈2.5 | 2.1 | Aşırı değerli | |
| F/D (MRQ) | 1.35Y ort. ≈1.2 | ≈1.2 | 2.1 | Düşük değerli | |
| EV / EBITDA | 12.85Y ort. ≈13.5 | ≈13.5 | 16.6 | Adil değer | |
| Fiyat / Serbest Nakit Akışı (TTM) | 16.05Y ort. ≈27.9 | ≈27.9 | · | · | |
| Fiyat / Nakit Akışı (TTM) | 10.55Y ort. ≈13.0 | ≈13.0 | 17.6 | Adil değer | |
| EV / Revenue (EV / Gelir) | 3.35Y ort. ≈3.1 | ≈3.1 | · | · | |
| EV / FCF | 31.25Y ort. ≈34.4 | ≈34.4 | · | · | |
| Fiyat / Maddi Defter Değeri (MRQ) | 1.65Y ort. ≈3.8 | ≈3.8 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | COO | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Brüt Kar Marjı (TTM) | 65.9%5Y ort. ≈65.9% | ≈65.9% | 58.2% | En üst düzey | |
| Faaliyet Kâr Marjı (TTM) | 12.8%5Y ort. ≈16.5% | ≈16.5% | 11.8% | En üst düzey | |
| FAVÖK Marjı (TTM) | 21.9%5Y ort. ≈22.3% | ≈22.3% | 17.6% | En üst düzey | |
| Vergi Öncesi Kar Marjı (TTM) | 10.9%5Y ort. ≈14.3% | ≈14.3% | 10.1% | En üst düzey | |
| Net Kâr Marjı (TTM) | 13.5%5Y ort. ≈28.0% | ≈28.0% | 6.7% | En üst düzey | |
| ROA (TTM) | 4.6%5Y ort. ≈9.7% | ≈9.7% | 3.5% | Aynı seviyede | |
| ROE (TTM) | 6.8%5Y ort. ≈14.8% | ≈14.8% | 6.5% | Ortalamanın altında | |
| ROIC | 4.2%5Y ort. ≈10.6% | ≈10.6% | 5.1% | Ortalamanın altında |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | COO | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Borç / Öz Sermaye (MRQ) | 0.35Y ort. ≈0.3 | ≈0.3 | 0.5 | Düşük borç | |
| Cari Oran (MRQ) | 1.25Y ort. ≈1.8 | ≈1.8 | 1.7 | Düşük likidite | |
| Quick Ratio (Cari Oran) | 0.85Y ort. ≈0.8 | ≈0.8 | 0.5 | Aynı seviyede | |
| Uzun Vadeli Borç / Özkaynak (MRQ) | 0.25Y ort. ≈0.3 | ≈0.3 | 0.8 | Düşük borç |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | COO | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | 5.1%5Y ort. ≈11.1% | ≈11.1% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | 7.3%5Y ort. ≈10.4% | ≈10.4% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | 11.0% | · | · | · | |
| EPS YoY (EPS YB) | -4.6%5Y ort. ≈207.5% | ≈207.5% | · | · | |
| Net Income YoY (Net Gelir Yıllık Bazda) | -4.4%5Y ort. ≈210.7% | ≈210.7% | · | · | |
| EPS CAGR 3Y (EPS Bileşik Yıllık Büyüme Oranı 3Y) | -1.2%5Y ort. ≈-33.9% | ≈-33.9% | · | · | |
| EPS CAGR 5Y (EPS Bileşik Yıllık Büyüme Oranı 5Y) | -17.2% | · | · | · | |
| Net Income CAGR 3Y (Net Gelir Bileşik Yıllık Büyüme Oranı 3Y) | -0.95%5Y ort. ≈-14.2% | ≈-14.2% | · | · | |
| Net Income CAGR 5Y (Net Gelir Bileşik Yıllık Büyüme Oranı 5Y) | 9.5% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | COO | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.35Y ort. ≈0.3 | ≈0.3 | 0.6 | Zayıf | |
| Inventory Turnover (Stok Devir Hızı) | 1.75Y ort. ≈1.8 | ≈1.8 | 2.7 | Zayıf | |
| Receivables Turnover (Alacak Devir Hızı) | 5.35Y ort. ≈5.9 | ≈5.9 | 7.7 | Zayıf | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$272.8K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Temettüler Temettü verimi, ödeme oranı, temettü geçmişi, 5 Yıllık CAGR
| Ex-tarihi | Miktar | Para Birimi | Temettü Verimi |
|---|---|---|---|
| Tem 26, 2023 | $0,01 | USD | ≈0.02% |
| Oca 20, 2023 | $0,01 | USD | ≈0.02% |
| Tem 26, 2022 | $0,01 | USD | ≈0.02% |
| Oca 20, 2022 | $0,01 | USD | ≈0.02% |
| Tem 26, 2021 | $0,01 | USD | ≈0.01% |
| Oca 21, 2021 | $0,01 | USD | ≈0.02% |
| Tem 22, 2020 | $0,01 | USD | ≈0.02% |
| Oca 22, 2020 | $0,01 | USD | ≈0.02% |
| Tem 22, 2019 | $0,01 | USD | ≈0.02% |
| Oca 18, 2019 | $0,01 | USD | ≈0.02% |
| Tem 20, 2018 | $0,01 | USD | ≈0.02% |
| Oca 22, 2018 | $0,01 | USD | ≈0.02% |
| Tem 19, 2017 | $0,01 | USD | ≈0.02% |
| Oca 19, 2017 | $0,01 | USD | ≈0.03% |
| Tem 20, 2016 | $0,01 | USD | ≈0.03% |
| Oca 20, 2016 | $0,01 | USD | ≈0.05% |
| Tem 22, 2015 | $0,01 | USD | ≈0.03% |
| Oca 21, 2015 | $0,01 | USD | ≈0.04% |
| Tem 22, 2014 | $0,01 | USD | ≈0.04% |
| Oca 22, 2014 | $0,01 | USD | ≈0.05% |
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Eylül 2026 | Eyl 9, 2026 | $1.15 | $1.13 | 1.8% |
| 30 Haziran 2026 | Haz 4, 2026 | $1.21 | $1.11 | 9.3% |
| 31 Mart 2026 | $1.10 | $1.04 | 5.7% | |
| 31 Aralık 2025 | $1.15 | $1.12 | 2.3% | |
| 30 Eylül 2025 | $1.10 | $1.08 | 1.9% | |
| 30 Haziran 2025 | $0.96 | $0.94 | 2.5% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.09B | $3.90B | $3.59B | $3.31B | $2.92B | $2.43B | $2.65B | $2.53B | $2.14B | $1.97B | $1.80B | $1.72B | |
| Cost of Revenue | $1.41B | $1.30B | $1.24B | $1.17B | $967M | $896M | $897M | $900M | $773M | $794M | $727M | $626M | |
| Gross Profit | $2.68B | $2.60B | $2.36B | $2.14B | $1.96B | $1.53B | $1.76B | $1.63B | $1.37B | $1.17B | $1.07B | $1.09B | |
| R&D Expense | $172M | $155M | $137M | $110M | $93M | $93M | $87M | $85M | $69M | $65M | $70M | $66M | |
| SG&A Expense | $1.63B | $1.53B | $1.50B | $1.34B | $1.21B | $992M | $996M | $973M | $799M | $723M | $712M | $683M | |
| Operating Income | $683M | $706M | $533M | $508M | $506M | $312M | $547M | $403M | $429M | $324M | $237M | $306M | |
| Interest Expense | · | · | $105M | $57M | $23M | $37M | $68M | $83M | $33M | $26M | $18M | $8M | |
| Other Non-op | $-16M | $-9M | $-15M | $25M | $9M | $-8M | $-1M | $12M | $-2M | $-2M | $-3M | $-2M | |
| Pretax Income | $566M | $582M | $413M | $475M | $492M | $266M | $477M | $332M | $394M | $296M | $216M | $296M | |
| Income Tax | $192M | $190M | $119M | $90M | $-2.45B | $28M | $11M | $192M | $21M | $21M | $10M | $25M | |
| Net Income | $375M | $392M | $294M | $386M | $2.94B | $238M | $467M | $140M | $373M | $274M | $204M | $270M | |
| EPS (Basic) | $1.88 | $1.97 | $1.49 | $1.95 | $59.80 | $4.85 | $9.44 | $2.85 | $7.63 | $5.65 | $4.20 | $5.61 | |
| EPS (Diluted) | $1.87 | $1.96 | $1.48 | $1.94 | $59.16 | $4.81 | $9.33 | $2.81 | $7.52 | $5.59 | $4.14 | $5.51 | |
| Shares (Basic) | 199,100,000 | 198,900,000 | 197,900,000 | 197,400,000 | 49,200,000 | 49,100,000 | 49,400,000 | 49,100,000 | 48,900,000 | 48,500,000 | 48,500,000 | 48,061,000 | |
| Shares (Diluted) | 200,000,000 | 200,400,000 | 199,300,000 | 198,800,000 | 49,800,000 | 49,600,000 | 50,000,000 | 49,700,000 | 49,600,000 | 49,000,000 | 49,200,000 | 49,000,000 | |
| EBITDA | $1.06B | $1.08B | $901M | $508M | $506M | $312M | $828M | $678M | $618M | $522M | $428M | $445M |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $111M | $108M | $121M | $138M | $96M | $116M | $89M | $78M | $89M | $101M | $16M | $25M | |
| Receivables | $829M | $717M | $610M | $558M | $515M | $435M | $435M | $375M | $317M | $291M | $283M | $276M | |
| Inventory | $846M | $803M | $736M | $629M | $586M | $570M | $507M | $469M | $454M | $418M | $420M | $382M | |
| Prepaid Expense | $321M | $324M | $239M | $209M | $179M | $152M | $132M | $170M | $94M | $78M | $81M | $68M | |
| Current Assets | $2.11B | $1.95B | $1.70B | $1.53B | $1.47B | $1.27B | $1.16B | $1.09B | $953M | $937M | $841M | $792M | |
| PP&E (Net) | $2.08B | $1.86B | $1.63B | $1.41B | $1.35B | $1.28B | $1.13B | $976M | $910M | $878M | $967M | $937M | |
| PP&E (Gross) | $3.91B | $3.56B | $3.18B | $2.80B | $2.66B | $2.47B | $2.19B | $1.93B | $1.76B | $1.60B | $1.65B | $1.53B | |
| Accum. Depreciation | $1.83B | $1.70B | $1.55B | $1.39B | $1.31B | $1.19B | $1.06B | $954M | $847M | $726M | $684M | $589M | |
| Goodwill | $3.85B | $3.84B | $3.62B | $3.61B | $2.57B | $2.45B | $2.43B | $2.39B | $2.35B | $2.16B | $2.20B | $2.22B | |
| Intangibles | $1.59B | $1.79B | $1.71B | $1.89B | $1.27B | $1.29B | $1.41B | $1.52B | $505M | $441M | $411M | $454M | |
| Other Non-current Assets | $689M | $661M | $637M | $588M | $401M | $105M | $67M | $74M | $76M | $52M | $39M | $39M | |
| Total Assets | $12.39B | $12.32B | $11.66B | $11.49B | $9.61B | $6.74B | $6.27B | $6.11B | $4.86B | $4.48B | $4.46B | $4.46B | |
| Accounts Payable | $300M | $260M | $262M | $249M | $161M | $176M | $150M | $146M | $142M | $107M | $117M | $116M | |
| Short-term Debt | $47M | $32M | $44M | $396M | $83M | $409M | $564M | $37M | $23M | $226M | $244M | $102M | |
| Current Liabilities | $1.11B | $1.02B | $969M | $1.28B | $732M | $1.00B | $1.11B | $536M | $396M | $543M | $569M | $442M | |
| Capital Leases | $240M | $231M | $216M | $206M | $232M | $237M | · | · | · | · | · | · | |
| Deferred Tax | $93M | $96M | $102M | $150M | $24M | $26M | $28M | $31M | $39M | $38M | $31M | $70M | |
| Other Non-current Liabilities | $283M | $312M | $239M | $225M | · | · | · | · | · | · | · | · | |
| Total Liabilities | $4.16B | $4.23B | $4.11B | $4.32B | $2.66B | $2.91B | $2.65B | $2.81B | $1.68B | $1.78B | $1.79B | $1.87B | |
| Long-term Debt | · | · | · | · | · | · | · | $1.99B | $1.15B | $1.32B | $1.11B | $1.28B | |
| Total Debt | $2.50B | $2.58B | $2.56B | $2.35B | $1.40B | $1.38B | $1.26B | $2.02B | $1.17B | $1.54B | $1.35B | $1.38B | |
| Common Stock | $22M | $22M | $22M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | |
| Paid-in Capital | $1.98B | $1.92B | $1.82B | $1.77B | $1.72B | $1.65B | $1.61B | $1.57B | $1.53B | $1.49B | $1.43B | $1.39B | |
| Retained Earnings | $7.64B | $7.27B | $6.88B | $6.58B | $6.20B | $3.26B | $3.03B | $2.58B | $2.43B | $2.05B | $1.78B | $1.58B | |
| Treasury Stock | $995M | $706M | $710M | $714M | $640M | $617M | $571M | $415M | $415M | $360M | $360M | $295M | |
| AOCI | $-406M | $-422M | $-454M | $-467M | $-341M | $-472M | $-447M | $-431M | $-375M | $-490M | $-192M | $-106M | |
| Stockholders' Equity | $8.24B | $8.08B | $7.55B | $7.17B | $6.94B | $3.82B | $3.63B | $3.31B | $3.18B | $2.70B | $2.67B | $2.57B | |
| Liabilities + Equity | $12.39B | $12.32B | $11.66B | $11.49B | $9.61B | $6.74B | $6.27B | $6.11B | $4.86B | $4.48B | $4.46B | $4.46B | |
| Shares Outstanding | 195,900,000 | 199,600,000 | 198,100,000 | 49,300,000 | 49,300,000 | 49,100,000 | · | · | 48,800,000 | 48,800,000 | 48,300,000 | 48,100,000 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $377M | $375M | $368M | $346M | $309M | · | $281M | $275M | $188M | $198M | $191M | $138M | |
| Stock-based Comp | $70M | $75M | $62M | $54M | $44M | $38M | $35M | $43M | $37M | $30M | $33M | $37M | |
| Deferred Tax | $135M | $119M | $45M | $54M | $-2.50B | $-900.0K | $-16M | $3M | $-7M | $-11M | $6M | $-16M | |
| Amort. of Intangibles | $199M | $201M | $186M | $180M | $146M | $137M | $146M | $147M | $68M | $61M | $52M | $36M | |
| Other Non-cash | $-162M | $-252M | $-161M | · | · | · | $-54M | $208M | $2M | $18M | $-42M | $26M | |
| Operating Cash Flow | $796M | $709M | $608M | $692M | $739M | $487M | $713M | $669M | $594M | $510M | $391M | $455M | |
| CapEx | $362M | $421M | $392M | $242M | $214M | $310M | $292M | $194M | $127M | $153M | $243M | $238M | |
| Investing Cash Flow | $-373M | $-765M | $-449M | $-1.83B | $-450M | $-364M | $-351M | $-1.52B | $-381M | $-419M | $-288M | $-1.35B | |
| Debt Issued | $3.11B | $3.52B | $2.12B | $1.51B | $1.43B | $3.20B | $1.14B | $2.75B | $1.41B | $1.58B | $1.20B | $2.56B | |
| Net Debt Issued | $-94M | $17M | $170M | $950M | $12M | $-30M | $-725M | $836M | $49M | $117M | $-171M | $895M | |
| Stock Repurchased | $290M | $0 | $0 | $78M | $25M | $48M | $156M | $0 | $55M | $0 | $67M | $76M | |
| Net Stock Activity | $-290M | $0 | $0 | $-78M | $-25M | $-48M | $-156M | $0 | $-55M | $0 | $-67M | $-76M | |
| Dividends Paid | $0 | $0 | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Financing Cash Flow | $-426M | $39M | $-174M | $1.19B | $-311M | $-96M | $-351M | $844M | $-228M | $-1M | $-107M | $842M | |
| Net Change in Cash | $3M | $-13M | $-18M | $42M | $-20M | $27M | $9M | $-9M | $-12M | $84M | $-9M | $-52M | |
| Taxes Paid | · | · | · | · | · | · | · | $19M | $16M | $29M | $12M | $16M | |
| Free Cash Flow | $434M | $288M | $215M | $450M | $524M | $176M | $421M | $475M | $466M | $357M | $148M | $217M | |
| Levered FCF | · | · | $140M | $404M | $386M | · | · | $440M | $435M | $333M | $131M | $209M |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 65.5% | 66.6% | 65.6% | 64.7% | 66.9% | 63.1% | 66.2% | 64.5% | 63.8% | 59.6% | 59.6% | 63.5% | |
| Operating Margin | 16.7% | 18.1% | 14.8% | 15.3% | 17.3% | 12.8% | 20.6% | 15.9% | 20.1% | 16.5% | 13.2% | 17.8% | |
| Net Margin | 9.2% | 10.1% | 8.2% | 11.7% | 100.8% | 9.8% | 17.6% | 5.5% | 17.4% | 13.9% | 11.3% | 15.7% | |
| Pretax Margin | 13.8% | 14.9% | 11.5% | 14.4% | 16.8% | · | · | 13.1% | 18.4% | 15.0% | 12.0% | 17.3% | |
| EBITDA Margin | 25.9% | 27.8% | 25.1% | 15.3% | 17.3% | 12.8% | 31.2% | 26.8% | 28.9% | 26.6% | 23.8% | 25.9% | |
| ROA | 3.0% | 3.3% | 2.5% | 3.7% | 36.0% | 3.7% | 7.5% | 2.5% | 8.0% | 6.1% | 4.6% | 7.1% | |
| ROE | 4.6% | 5.0% | 4.0% | 5.5% | 54.7% | 6.4% | 13.0% | 4.3% | 12.7% | 10.2% | 7.8% | 10.8% | |
| ROIC | 4.2% | 4.5% | 3.8% | 4.3% | 36.3% | · | · | 3.2% | 9.3% | 7.1% | 5.6% | 7.1% |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | 1.9 | 1.8 | 1.2 | 2.0 | 1.3 | 1.0 | 2.0 | 2.4 | 1.7 | 1.5 | 1.8 | |
| Quick Ratio | 0.8 | 0.8 | 0.8 | 0.5 | 0.8 | 0.5 | 0.5 | 0.8 | 1.0 | 0.7 | 0.5 | 0.7 | |
| Debt / Equity | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.4 | 0.3 | 0.6 | 0.4 | 0.6 | 0.5 | 0.5 | |
| LT Debt / Equity | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.4 | 0.3 | 0.6 | 0.4 | 0.4 | 0.4 | 0.5 | |
| Interest Coverage | · | · | 5.1 | 8.9 | 21.9 | 8.5 | 8.0 | 4.9 | 12.8 | 12.4 | 13.1 | 38.5 |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | 0.3 | 0.3 | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | 0.4 | 0.4 | 0.5 | |
| Inventory Turnover | 1.7 | 1.7 | 1.8 | 1.9 | 1.7 | 1.7 | 1.8 | 2.0 | 1.8 | 1.9 | 1.8 | 1.7 | |
| Receivables Turnover | 5.3 | 5.9 | 6.2 | 6.2 | 6.1 | 5.6 | 6.6 | 7.3 | 7.0 | 6.8 | 6.4 | 6.8 |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $42.06 | $40.50 | $152.54 | $145.53 | $140.81 | · | · | · | $65.08 | $55.34 | $55.26 | $53.38 | |
| Revenue / Share | $20.46 | $19.44 | $72.15 | $66.57 | $58.68 | $49.01 | $53.07 | $50.96 | $43.12 | $40.14 | $36.54 | $35.09 | |
| Cash Flow / Share | $3.98 | $3.54 | $12.20 | $13.93 | $14.83 | $9.81 | $14.26 | $13.46 | $11.97 | $10.40 | $7.95 | $9.29 | |
| Cash / Share | $0.56 | $0.54 | $2.44 | $2.80 | $1.95 | · | · | · | $1.82 | $2.07 | $0.34 | $0.52 | |
| Dividend / Share | · | · | $0.01 | $0.01 | · | · | · | · | · | · | · | · | |
| Dividend Paid / Share | · | · | $0.03 | $0.03 | $0.03 | $0.03 | $0.03 | $0.03 | $0.03 | $0.03 | $0.03 | $0.03 | |
| EPS (TTM) | $1.87 | $1.96 | $1.48 | $1.94 | $59.16 | $4.81 | $9.33 | $2.81 | $7.52 | $5.59 | $4.14 | $5.51 |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 5.1% | 8.4% | 8.6% | 13.2% | 20.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 7.3% | 10.1% | 13.9% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -4.6% | 32.4% | -23.7% | -96.7% | 1129.9% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -1.2% | -67.9% | -32.5% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -17.2% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -4.4% | 33.3% | -23.7% | -86.9% | 1135.2% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -0.95% | -48.9% | 7.3% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 9.5% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.09B | $3.90B | $3.59B | $3.31B | $2.92B | $2.43B | $2.65B | $2.53B | $2.14B | $1.97B | $1.80B | $1.72B | |
| Net Income TTM | $375M | $392M | $294M | $386M | $2.94B | $238M | $467M | $140M | $373M | $274M | $204M | $270M | |
| Market Cap | $13.70B | $20.89B | $3.86B | $3.37B | $5.14B | · | · | · | $2.93B | $2.15B | $1.84B | $1.97B | |
| Enterprise Value | $16.09B | $23.37B | $6.30B | $5.58B | $6.44B | · | · | · | $4.02B | $3.59B | $3.18B | $3.33B | |
| P/E | 37.4 | 53.4 | 52.7 | 35.2 | 1.8 | 16.6 | 7.8 | 23.0 | 8.0 | 7.9 | 9.2 | 7.4 | |
| P/S | 3.3 | 5.4 | 1.1 | 1.0 | 1.8 | · | · | · | 1.4 | 1.1 | 1.0 | 1.1 | |
| P/B | 1.7 | 2.6 | 0.5 | 0.5 | 0.7 | · | · | · | 0.9 | 0.8 | 0.7 | 0.8 | |
| P / Tangible Book | 4.9 | 8.5 | 1.7 | 2.0 | 1.7 | · | · | · | · | · | · | · | |
| P / Cash Flow | 17.2 | 29.5 | 6.4 | 4.9 | 7.0 | · | · | · | 4.9 | 4.2 | 4.7 | 4.3 | |
| P / FCF | 31.6 | 72.5 | 17.9 | 7.5 | 9.8 | · | · | · | 6.3 | 6.0 | 12.4 | 9.1 | |
| EV / EBITDA | 15.2 | 21.6 | 7.0 | 11.0 | 12.7 | · | · | · | 6.5 | 6.9 | 7.4 | 7.5 | |
| EV / FCF | 37.1 | 81.1 | 29.3 | 12.4 | 12.3 | · | · | · | 8.6 | 10.1 | 21.5 | 15.4 | |
| EV / Revenue | 3.9 | 6.0 | 1.8 | 1.7 | 2.2 | · | · | · | 1.9 | 1.8 | 1.8 | 1.9 | |
| Dividend Yield | 0.00% | 0.00% | 0.08% | 0.09% | 0.06% | · | · | · | 0.10% | 0.14% | 0.16% | 0.15% | |
| Earnings Yield | 2.7% | 1.9% | 1.9% | 2.8% | 56.8% | 6.0% | 12.8% | 4.3% | 12.5% | 12.7% | 10.9% | 13.5% | |
| Payout Ratio | 0.00% | 0.00% | 1.0% | 0.78% | 0.10% | 1.3% | 0.64% | 2.1% | 0.78% | 1.1% | 1.4% | 1.1% | |
| Annual Payout | $0 | $0 | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M |
Gelir Tablosu
| Metrik | Eğilim | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.07B | $1.08B | $1.02B | $1.07B | $1.06B | $1.00B | $965M | $1.02B | $1.00B | $943M | $932M | $927M | $930M | $877M | $858M | $848M | |
| Cost of Revenue | $354M | $346M | $329M | $414M | $368M | $323M | $304M | $341M | $340M | $311M | $308M | $321M | $320M | $294M | $300M | $311M | |
| Gross Profit | $712M | $735M | $695M | $651M | $692M | $679M | $660M | $678M | $663M | $631M | $624M | $606M | $610M | $583M | $558M | $537M | |
| R&D Expense | $42M | $42M | $44M | $41M | $45M | $46M | $41M | $38M | $39M | $39M | $40M | $37M | $36M | $33M | $32M | $29M | |
| SG&A Expense | $401M | $676M | $390M | $419M | $422M | $399M | $388M | $391M | $381M | $380M | $381M | $388M | $375M | $408M | $331M | $358M | |
| Operating Income | $222M | $-31M | $213M | $140M | $176M | $185M | $182M | $198M | $192M | $162M | $153M | $136M | $152M | $96M | $150M | $104M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $29M | $30M | · | $27M | $26M | $26M | · | |
| Other Non-op | $1M | $4M | $2M | $800.0K | $2M | $-16M | $-3M | $-3M | $-300.0K | $-3M | $-3M | $-3M | $-6M | $-5M | $-1M | $-8M | |
| Pretax Income | $202M | $-48M | $192M | $117M | $152M | $144M | $153M | $169M | $164M | $130M | $120M | $106M | $119M | $66M | $122M | $72M | |
| Income Tax | $-231M | $30M | $61M | $32M | $54M | $57M | $49M | $51M | $59M | $41M | $39M | $22M | $34M | $26M | $38M | $7M | |
| Net Income | $433M | $-78M | $131M | $85M | $98M | $88M | $104M | $118M | $105M | $89M | $81M | $84M | $85M | $40M | $85M | $66M | |
| EPS (Basic) | $2.24 | $-0.40 | $0.67 | $0.43 | $0.49 | $0.44 | $0.52 | $0.58 | $0.53 | $0.45 | $0.41 | $0.43 | $0.43 | $0.20 | $0.43 | $-4.54 | |
| EPS (Diluted) | $2.24 | $-0.40 | $0.66 | $0.42 | $0.49 | $0.44 | $0.52 | $0.59 | $0.52 | $0.44 | $0.41 | $0.42 | $0.43 | $0.20 | $0.43 | $-4.50 | |
| Shares (Basic) | 193,000,000 | 195,000,000 | 195,800,000 | · | 199,300,000 | 199,900,000 | 199,700,000 | · | 199,100,000 | 198,900,000 | 198,400,000 | · | 198,100,000 | 197,900,000 | 197,500,000 | · | |
| Shares (Diluted) | 193,400,000 | 195,000,000 | 196,700,000 | · | 200,000,000 | 200,700,000 | 201,200,000 | · | 200,600,000 | 200,500,000 | 199,900,000 | · | 199,600,000 | 199,200,000 | 198,700,000 | · | |
| EBITDA | $222M | $-31M | $308M | · | $176M | $185M | $273M | · | $192M | $162M | $250M | · | $152M | $96M | $239M | · |
Bilanço
| Metrik | Eğilim | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $155M | $139M | $125M | $111M | $125M | $116M | $101M | $108M | $110M | $112M | $135M | $121M | $117M | $112M | $118M | $138M | |
| Receivables | $789M | $809M | $807M | $829M | $792M | $781M | $716M | $717M | $739M | $689M | $651M | · | $630M | $565M | $582M | · | |
| Inventory | $912M | $896M | $876M | $846M | $881M | $880M | $843M | $803M | $779M | $775M | $748M | · | $724M | $699M | $659M | · | |
| Prepaid Expense | $426M | $455M | $325M | $321M | $340M | $348M | $327M | $324M | $299M | $282M | $260M | · | $240M | $224M | $218M | · | |
| Current Assets | $2.28B | $2.30B | $2.13B | $2.11B | $2.14B | $2.13B | $1.99B | $1.95B | $1.93B | $1.86B | $1.79B | · | $1.71B | $1.60B | $1.58B | · | |
| PP&E (Net) | · | · | · | $2.08B | · | · | · | $1.86B | $1.75B | $1.71B | $1.68B | · | $1.53B | $1.49B | $1.46B | · | |
| PP&E (Gross) | · | · | · | $3.91B | · | · | · | $3.56B | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | · | $1.83B | · | · | · | $1.70B | · | · | · | · | · | · | · | · | |
| Goodwill | $3.88B | $3.89B | $3.91B | $3.85B | $3.86B | $3.86B | $3.79B | $3.84B | $3.78B | $3.76B | $3.77B | · | $3.68B | $3.66B | $3.67B | · | |
| Intangibles | $1.45B | $1.49B | $1.54B | $1.59B | $1.64B | $1.69B | $1.74B | $1.79B | $1.79B | $1.80B | $1.85B | · | $1.77B | $1.81B | $1.86B | · | |
| Other Non-current Assets | $657M | $673M | $688M | $689M | $653M | $659M | $664M | $661M | $621M | $637M | $617M | · | $628M | $585M | $569M | · | |
| Total Assets | $12.67B | $12.48B | $12.42B | $12.39B | $12.38B | $12.41B | $12.22B | $12.32B | $12.11B | $12.05B | $12.03B | $11.66B | $11.70B | $11.54B | $11.56B | $11.49B | |
| Accounts Payable | $251M | $233M | $226M | $300M | $256M | $244M | $202M | $260M | $222M | $231M | $202M | · | $227M | $242M | $224M | · | |
| Short-term Debt | $628M | $598M | $620M | $47M | $46M | $59M | $48M | $32M | $40M | $41M | $45M | · | $63M | $58M | $52M | · | |
| Current Liabilities | $1.87B | $1.80B | $1.60B | $1.11B | $1.01B | $1.01B | $1000M | $1.02B | $970M | $952M | $965M | · | $994M | $949M | $916M | · | |
| Capital Leases | · | · | · | $240M | · | · | · | $231M | · | · | · | · | · | · | · | · | |
| Deferred Tax | $94M | $96M | $96M | $93M | $102M | $99M | $95M | $96M | $95M | $94M | $90M | · | $138M | $139M | $144M | · | |
| Other Non-current Liabilities | $257M | $266M | $277M | $283M | $263M | $274M | $261M | $312M | $277M | $278M | $281M | · | · | · | · | · | |
| Total Liabilities | $4.34B | $4.24B | $4.06B | $4.16B | $4.02B | $4.13B | $4.09B | $4.23B | $4.18B | $4.24B | $4.34B | · | $4.17B | $4.16B | $4.23B | · | |
| Total Debt | $2.54B | $2.46B | $2.50B | · | $2.48B | $2.58B | $2.54B | · | $2.63B | $2.71B | $2.77B | · | $2.57B | $2.62B | $2.68B | · | |
| Common Stock | $22M | $22M | $22M | $22M | $22M | $22M | $22M | $22M | $22M | $22M | $22M | · | $5M | $5M | $5M | · | |
| Paid-in Capital | $2.00B | $1.98B | $1.99B | $1.98B | $1.96B | $1.94B | $1.93B | $1.92B | $1.88B | $1.87B | $1.85B | · | $1.82B | $1.80B | $1.78B | · | |
| Retained Earnings | $8.13B | $7.70B | $7.77B | $7.64B | $7.56B | $7.46B | $7.37B | $7.27B | $7.15B | $7.05B | $6.96B | · | $6.79B | $6.71B | $6.67B | · | |
| Treasury Stock | $1.44B | $1.10B | $1.09B | $995M | $796M | $745M | $705M | $706M | $707M | $708M | $709M | · | $711M | $712M | $713M | · | |
| AOCI | $-383M | $-363M | $-334M | $-406M | $-392M | $-392M | $-490M | $-422M | $-425M | $-423M | $-422M | · | $-375M | $-424M | $-404M | · | |
| Stockholders' Equity | $8.33B | $8.24B | $8.36B | $8.24B | $8.35B | $8.29B | $8.13B | $8.08B | $7.92B | $7.80B | $7.70B | · | $7.53B | $7.38B | $7.34B | · | |
| Liabilities + Equity | $12.67B | $12.48B | $12.42B | $12.39B | $12.38B | $12.41B | $12.22B | $12.32B | $12.11B | $12.05B | $12.03B | · | $11.70B | $11.54B | $11.56B | · | |
| Shares Outstanding | 190,100,000 | 194,900,000 | 195,100,000 | 195,900,000 | 198,800,000 | 199,500,000 | 199,900,000 | 199,600,000 | 199,100,000 | 199,100,000 | 198,700,000 | · | 49,500,000 | 49,500,000 | 49,400,000 | · |
Nakit Akışı
| Metrik | Eğilim | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $95M | $95M | $96M | $98M | $95M | $93M | $91M | $91M | $89M | $98M | $97M | $93M | $94M | $91M | $90M | $89M | |
| Deferred Tax | $-275M | $44M | $44M | $13M | $44M | $44M | $35M | $22M | $36M | $32M | $29M | · | · | · | · | $-1M | |
| Amort. of Intangibles | $47M | $48M | $48M | $50M | $50M | $50M | $50M | $50M | $50M | $50M | $50M | $46M | $47M | $46M | $46M | $46M | |
| Other Non-cash | · | · | $-45M | · | · | · | $-115M | · | · | · | $-165M | · | · | · | $-36M | · | |
| Operating Cash Flow | $342M | $183M | $261M | $248M | $261M | $96M | $191M | $268M | $208M | $111M | $123M | $174M | $142M | $124M | $167M | $131M | |
| CapEx | $69M | $86M | $102M | $98M | $97M | $78M | $89M | $140M | $89M | $74M | $118M | $145M | $91M | $74M | $83M | $95M | |
| Investing Cash Flow | $-70M | $-90M | $-103M | $-99M | $-98M | $-79M | $-97M | $-242M | $-124M | $-75M | $-324M | $-161M | $-93M | $-82M | $-113M | $-100M | |
| Debt Issued | $1.11B | $858M | $875M | $936M | $756M | $749M | $670M | $716M | $1.40B | $608M | $795M | $472M | $453M | $497M | $702M | $12M | |
| Net Debt Issued | · | · | $-29M | · | · | · | $-59M | · | · | · | $202M | · | · | · | $276M | · | |
| Stock Repurchased | $339M | $16M | $92M | $197M | $53M | $41M | $0 | $0 | $0 | · | · | $0 | $0 | $0 | $0 | $0 | |
| Net Stock Activity | · | · | $-92M | · | · | · | · | · | · | · | · | · | · | · | $0 | · | |
| Dividends Paid | · | · | · | · | · | · | · | $0 | $0 | · | · | $2M | $0 | · | · | $2M | |
| Financing Cash Flow | $-253M | $-76M | $-148M | $-164M | $-156M | $-9M | $-97M | $-28M | $-88M | $-57M | $212M | $-6M | $-43M | $-47M | $-78M | $-134M | |
| Net Change in Cash | $16M | $14M | $14M | $-14M | $9M | $15M | $-7M | $-2M | $-3M | $-23M | $14M | $3M | $5M | $-6M | $-20M | $-108M | |
| Free Cash Flow | · | · | $159M | · | · | · | $101M | · | · | · | $5M | · | · | · | $84M | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | $-16M | · | · | · | $66M | · |
Kârlılık
| Metrik | Eğilim | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 66.8% | 68.0% | 67.9% | · | 65.3% | 67.8% | 68.4% | · | 66.1% | 67.0% | 67.0% | · | 65.6% | 66.4% | 65.1% | · | |
| Operating Margin | 20.8% | -2.9% | 20.8% | · | 16.6% | 18.4% | 18.9% | · | 19.2% | 17.2% | 16.4% | · | 16.3% | 11.0% | 17.4% | · | |
| Net Margin | 40.6% | -7.2% | 12.8% | · | 9.3% | 8.8% | 10.8% | · | 10.4% | 9.4% | 8.7% | · | 9.2% | 4.5% | 9.8% | · | |
| Pretax Margin | 18.9% | -4.5% | 18.8% | · | 14.3% | 14.4% | 15.9% | · | 16.3% | 13.8% | 12.9% | · | 12.8% | 7.5% | 14.2% | · | |
| EBITDA Margin | 20.8% | -2.9% | 30.1% | · | 16.6% | 18.4% | 28.3% | · | 19.2% | 17.2% | 26.8% | · | 16.3% | 11.0% | 27.9% | · | |
| ROA | 3.5% | -0.63% | 1.1% | · | 0.80% | 0.72% | 0.86% | · | 0.88% | 0.75% | 0.69% | · | 0.73% | 0.34% | 0.73% | · | |
| ROE | 5.2% | -0.94% | 1.6% | · | 1.2% | 1.1% | 1.3% | · | 1.4% | 1.2% | 1.1% | · | 1.2% | 0.55% | 1.2% | · | |
| ROIC | 4.4% | -0.47% | 1.3% | · | 1.1% | 1.0% | 1.2% | · | 1.2% | 1.1% | 0.99% | · | 1.1% | 0.58% | 1.0% | · |
Likidite ve Solventlik
| Metrik | Eğilim | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | 1.3 | 1.3 | · | 2.1 | 2.1 | 2.0 | · | 2.0 | 2.0 | 1.9 | · | 1.7 | 1.7 | 1.7 | · | |
| Quick Ratio | 0.5 | 0.5 | 0.6 | · | 0.9 | 0.9 | 0.8 | · | 0.9 | 0.8 | 0.8 | · | 0.8 | 0.7 | 0.8 | · | |
| Debt / Equity | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.4 | · | 0.3 | 0.4 | 0.4 | · | |
| LT Debt / Equity | 0.2 | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.4 | · | 0.3 | 0.3 | 0.4 | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 5.6 | 5.1 | · | 5.7 | 3.7 | 5.7 | · |
Verimlilik
| Metrik | Eğilim | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | |
| Inventory Turnover | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.5 | · | |
| Receivables Turnover | 1.3 | 1.4 | 1.3 | · | 1.4 | 1.4 | 1.4 | · | 1.5 | 1.5 | 1.5 | · | 1.6 | 1.6 | 1.6 | · |
Hisse Başına
| Metrik | Eğilim | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $43.81 | $42.27 | $42.87 | · | $42.02 | $41.54 | $40.66 | · | $39.80 | $39.19 | $38.73 | · | $152.09 | $149.05 | $148.49 | · | |
| Revenue / Share | $5.51 | $5.55 | $5.21 | · | $5.30 | $4.99 | $4.79 | · | $5.00 | $4.70 | $4.66 | · | $18.64 | $17.62 | $17.27 | · | |
| Cash Flow / Share | · | · | $1.33 | · | · | · | $0.95 | · | · | · | $0.61 | · | · | · | $3.35 | · | |
| Cash / Share | $0.81 | $0.71 | $0.64 | · | $0.63 | $0.58 | $0.50 | · | $0.55 | $0.56 | $0.68 | · | $2.37 | $2.26 | $2.39 | · | |
| Dividend Paid / Share | · | · | · | · | · | · | · | · | · | · | · | · | $0.01 | · | $0.01 | · | |
| EPS (TTM) | $2.92 | $1.17 | $2.01 | · | $2.04 | $2.07 | $2.07 | · | $1.79 | $1.70 | $1.46 | · | $-3.44 | $-1.89 | $0.46 | · |
Değerleme (TTM)
| Metrik | Eğilim | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.24B | $4.23B | $4.15B | · | $4.05B | $3.99B | $3.93B | · | $3.80B | $3.73B | $3.67B | · | $3.51B | $3.43B | $3.38B | · | |
| Net Income TTM | $570M | $236M | $401M | · | $408M | $414M | $415M | · | $359M | $340M | $291M | · | $275M | $288M | $375M | · | |
| Market Cap | $13.75B | $12.26B | $15.81B | · | $14.05B | $16.29B | $19.30B | · | $18.58B | $17.73B | $18.53B | · | $4.84B | $4.72B | $4.31B | · | |
| Enterprise Value | $16.14B | $14.58B | $18.18B | · | $16.40B | $18.76B | $21.74B | · | $21.10B | $20.33B | $21.16B | · | $7.30B | $7.23B | $6.87B | · | |
| P/E | 24.8 | 53.8 | 40.3 | · | 34.7 | 39.5 | 46.6 | · | 52.1 | 52.4 | 63.9 | · | -28.4 | -50.5 | 189.6 | · | |
| P/S | 3.2 | 2.9 | 3.8 | · | 3.5 | 4.1 | 4.9 | · | 4.9 | 4.8 | 5.1 | · | 1.4 | 1.4 | 1.3 | · | |
| P/B | 1.7 | 1.5 | 1.9 | · | 1.7 | 2.0 | 2.4 | · | 2.3 | 2.3 | 2.4 | · | 0.6 | 0.6 | 0.6 | · | |
| P / Tangible Book | 4.6 | 4.3 | 5.4 | · | 4.9 | 6.0 | 7.4 | · | 7.9 | 7.9 | 8.9 | · | 2.3 | 2.5 | 2.4 | · | |
| P / Cash Flow | · | · | 60.6 | · | · | · | 101.3 | · | · | · | 151.0 | · | · | · | 25.9 | · | |
| EV / Revenue | 3.8 | 3.4 | 4.4 | · | 4.1 | 4.7 | 5.5 | · | 5.5 | 5.4 | 5.8 | · | 2.1 | 2.1 | 2.0 | · | |
| Earnings Yield | 4.0% | 1.9% | 2.5% | · | 2.9% | 2.5% | 2.1% | · | 1.9% | 1.9% | 1.6% | · | -3.5% | -2.0% | 0.53% | · |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
|---|---|---|---|---|---|
| Gelir | $4.09B | $3.90B | $3.59B | $3.31B | $2.92B |
| Brüt Kâr Marjı % | 65.5% | 66.6% | 65.6% | 64.7% | 66.9% |
| Faaliyet Kâr Marjı % | 16.7% | 18.1% | 14.8% | 15.3% | 17.3% |
| Net Gelir | $375M | $392M | $294M | $386M | $2.94B |
| Seyreltilmiş Hisse Başı Kâr | $1.87 | $1.96 | $1.48 | $1.94 | $59.16 |
| Metrik | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 |
| Cari Oran | 1.9 | 1.9 | 1.8 | 1.2 | 2.0 |
| Cari Oran | 0.8 | 0.8 | 0.8 | 0.5 | 0.8 |
| Metrik | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $434M | $288M | $215M | $450M | $524M |
Kurumsal Sahipler (13F) 734 dosya · $15.9B toplam · Tarih itibarıyla 30 Eylül 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 110 (-5 önceki Ç'ye göre) | 98 (+14 önceki Ç'ye göre) | 259 (+25 önceki Ç'ye göre) | 236 (-6 önceki Ç'ye göre) | +2.5M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| VANGUARD GROUP INC | $1.930.069.728 | 23.548.923 | 12,11% | Hisse senetleri |
| BlackRock, Inc. | $1.077.762.042 | 15.029.453 | 6,76% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $914.931.325 | 12.758.769 | 5,74% | Hisse senetleri |
| STATE STREET CORP | $637.691.430 | 8.892.643 | 4,00% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $621.703.470 | 8.669.690 | 3,90% | Hisse senetleri |
| BROWNING WEST LP | $515.984.142 | 7.195.428 | 3,24% | Hisse senetleri |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | $389.405.563 | 5.430.282 | 2,44% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $382.865.202 | 5.359.812 | 2,40% | Hisse senetleri |
| FRANKLIN RESOURCES INC | $365.497.867 | 5.096.888 | 2,29% | Hisse senetleri |
| GENERATION INVESTMENT MANAGEMENT LLP | $356.303.541 | 4.968.673 | 2,24% | Hisse senetleri |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $287.152.440 | 4.004.357 | 1,80% | Hisse senetleri |
| AQR CAPITAL MANAGEMENT LLC | $285.686.067 | 4.022.614 | 1,79% | Hisse senetleri |
| Longview Partners (Guernsey) LTD | $282.537.902 | 3.940.007 | 1,77% | Hisse senetleri |
| UBS Group AG | $281.964.653 | 3.932.013 | 1,77% | Hisse senetleri |
| CITADEL ADVISORS LLC | $277.689.589 | 3.872.397 | 1,74% | Hisse senetleri |
| Invesco Ltd. | $264.254.073 | 3.685.038 | 1,66% | Hisse senetleri |
| JANA Partners Management, LP | $256.899.641 | 3.582.480 | 1,61% | Hisse senetleri |
| WELLINGTON MANAGEMENT GROUP LLP | $248.758.476 | 3.468.951 | 1,56% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $239.621.575 | 3.341.607 | 1,50% | Hisse senetleri |
| JANUS HENDERSON GROUP PLC | $219.298.853 | 3.067.125 | 1,38% | Hisse senetleri |
| LONDON CO OF VIRGINIA | $207.821.082 | 2.898.075 | 1,30% | Hisse senetleri |
| Diamond Hill Capital Management, LLC (Investment Advisor) | $195.854.209 | 2.731.198 | 1,23% | Hisse senetleri |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $187.836.665 | 2.343.776 | 1,18% | Hisse senetleri |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $180.899.937 | 2.530.069 | 1,14% | Hisse senetleri |
| BARCLAYS PLC | $152.030.580 | 2.120.075 | 0,95% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $144.125.264 | 2.009.835 | 0,90% | Hisse senetleri |
| River Road Asset Management, LLC | $142.048.546 | 1.980.875 | 0,89% | Hisse senetleri |
| Sustainable Growth Advisers, LP | $139.698.824 | 1.948.108 | 0,88% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $132.231.017 | 1.843.969 | 0,83% | Hisse senetleri |
| MORGAN STANLEY | $129.451.390 | 1.805.205 | 0,81% | Hisse senetleri |
| NORTHERN TRUST CORP | $122.198.356 | 1.704.063 | 0,77% | Hisse senetleri |
| Gates Capital Management, Inc. | $121.088.717 | 1.688.589 | 0,76% | Hisse senetleri |
| Alecta Tjanstepension Omsesidigt | $112.082.730 | 1.563.000 | 0,70% | Hisse senetleri |
| MANNING & NAPIER ADVISORS LLC | $107.938.609 | 1.505.210 | 0,68% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $107.170.245 | 1.494.495 | 0,67% | Hisse senetleri |
| Amundi | $101.548.173 | 1.416.095 | 0,64% | Hisse senetleri |
| Focus Partners Wealth | $101.143.265 | 1.410.461 | 0,63% | Hisse senetleri |
| Findlay Park Partners LLP | $92.075.640 | 1.284.000 | 0,58% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $82.870.197 | 1.155.630 | 0,52% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $78.580.965 | 1.095.816 | 0,49% | Hisse senetleri |
| Holocene Advisors, LP | $77.495.348 | 1.080.677 | 0,49% | Hisse senetleri |
| Bank of New York Mellon Corp | $73.642.162 | 1.026.945 | 0,46% | Hisse senetleri |
| Balyasny Asset Management L.P. | $71.022.946 | 990.419 | 0,45% | Hisse senetleri |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $69.128.942 | 964.007 | 0,43% | Hisse senetleri |
| FMR LLC | $66.919.501 | 933.197 | 0,42% | Hisse senetleri |
| ENVESTNET ASSET MANAGEMENT INC | $63.808.602 | 889.815 | 0,40% | Hisse senetleri |
| JPMORGAN CHASE & CO | $63.430.969 | 879.426 | 0,40% | Hisse senetleri |
| DEUTSCHE BANK AG\ | $61.203.267 | 853.483 | 0,38% | Hisse senetleri |
| Legal & General Group Plc | $60.521.302 | 843.973 | 0,38% | Hisse senetleri |
| TORONTO DOMINION BANK | $56.349.846 | 785.802 | 0,35% | Hisse senetleri |
Şirket yöneticileri 51 içeriden öğrenenler · 25 yöneticiler · 21 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Robert D Auerbach | Special Advisor to the CEO | 01 Şubat 2021 M | 2.759 | 0 | 0 | $0 |
| REMMELL PAUL L | Pres & CEO - CooperSurgical | 14 Temmuz 2017 M | 1.352 | 0 | 0 | $0 |
| Nicholas J Pichotta | Pres, CEO Cooper Medical, Inc. | 08 Ocak 2014 M | 10.697 | 0 | 0 | $0 |
| Brian G Andrews | EVP, CFO & Treasurer | 10 Aralık 2024 A | 8.537 | 0 | 0 | $0 |
| Gregory W Matz | SVP, CFO & CRO | 13 Haziran 2016 M | 15.123 | 0 | 0 | $0 |
| Steven M Neil | EVP & CFO | 16 Ocak 2008 P | 4.300 | 0 | 0 | $0 |
| John J Calcagno | CFO - CooperVision | 25 Ekim 2007 A | 0 | 0 | 0 | $0 |
| Gerard H Warner III | President, CooperVision, Inc. | 08 Ocak 2026 M | 23.852 | 0 | 0 | $0 |
| Holly R Sheffield | President, CSI | 08 Ocak 2026 M | 43.261 | 1 | 0 | $99.322 |
| John Arthur Weber | President, CooperVision, Inc. | 08 Ocak 2014 M | 15.260 | 0 | 0 | $0 |
| Dennis Murphy | President Americas, CVI | 11 Eylül 2009 M | 0 | 0 | 0 | $0 |
| Gregory A Fryling | Pres & COO - CVI | 24 Ekim 2006 A | 3.790 | 0 | 0 | $0 |
| Agostino Ricupati | SVP & CAO | 01 Nisan 2025 M | 8.020 | 0 | 0 | $0 |
| Nicholas Khadder | VP, General Counsel & Corp Sec | 08 Ocak 2025 M | 2.506 | 0 | 0 | $0 |
| Mark J Drury | VP, General Counsel & Sec. | 08 Ocak 2022 M | 2.197 | 0 | 0 | $0 |
| Randal Golden | VP, General Counsel & Sec. | 03 Şubat 2020 M | 1.673 | 0 | 0 | $0 |
| Carol R Kaufman | EVP, Sec. & Chief Gov. Officer | 11 Nisan 2018 G | 45.898 | 0 | 0 | $0 |
| Tina Maloney | VP, Corporate Controller | 08 Ocak 2017 M | 2.874 | 0 | 0 | $0 |
| Rodney Folden | VP & Corporate Controller | 08 Ocak 2014 M | 8.592 | 0 | 0 | $0 |
| Eugene J Midlock | VP Tax | 09 Ocak 2012 M | 2.137 | 0 | 0 | $0 |
| Jeffrey Alan Mclean | Exec VP, Comm. Strategies-CVI | 11 Aralık 2008 A | 0 | 0 | 0 | $0 |
| Christopher J Marmo | VP, R&D of CooperVision, Inc. | 24 Ekim 2006 A | · | 0 | 0 | $0 |
| Norris B Battin | VP, Investor Relations | 24 Ekim 2006 A | 4.000 | 0 | 0 | $0 |
| David Acosta | Treasurer | 08 Nisan 2005 S | 10.000 | 0 | 0 | $0 |
| Stephen Whiteford | VP, Corporate Controller | 20 Ocak 2004 M | 15.052 | 0 | 0 | $0 |
| Lawrence E. Kurzius | Yönetim kurulu üyesi | 16 Eylül 2026 P | 31.099 | 3 | 0 | $1.253.500 |
| Walter M Rosebrough Jr | Yönetim kurulu üyesi | 14 Eylül 2026 P | 20.000 | 2 | 0 | $541.640 |
| Keel Paul A | Yönetim kurulu üyesi | 11 Eylül 2026 P | 4.701 | 1 | 0 | $249.999 |
| Barbara Carbone | Yönetim kurulu üyesi | 01 Nisan 2026 A | 3.050 | 0 | 0 | $0 |
| Maria Rivas | Yönetim kurulu üyesi | 01 Nisan 2026 A | 3.322 | 1 | 0 | $82.130 |
| Colleen Jay | Yönetim kurulu üyesi | 01 Nisan 2026 A | 39.907 | 0 | 0 | $0 |
| Robert S Weiss | Yönetim kurulu üyesi | 01 Nisan 2026 A | 292.599 | 0 | 0 | $0 |
| MADDEN TERESA S | Yönetim kurulu üyesi | 01 Nisan 2026 A | 15.679 | 0 | 0 | $0 |
| William A Kozy | Yönetim kurulu üyesi | 01 Nisan 2025 M | 31.149 | 0 | 0 | $0 |
| Gary S Petersmeyer | Yönetim kurulu üyesi | 22 Mart 2024 G | 1.523 | 0 | 0 | $0 |
| Jody S Lindell | Yönetim kurulu üyesi | 06 Ocak 2023 M | 13.543 | 0 | 0 | $0 |
| Michael Kalkstein | Yönetim kurulu üyesi | 01 Nisan 2020 M | 0 | 0 | 0 | $0 |
| Allan E Rubenstein | Yönetim kurulu üyesi | 01 Nisan 2020 A | 3.091 | 0 | 0 | $0 |
| Thomas A Bender | Yönetim kurulu üyesi | 01 Nisan 2020 A | 12.952 | 0 | 0 | $0 |
| Stanley Zinberg MD | Yönetim kurulu üyesi | 12 Mart 2019 M | 10.528 | 0 | 0 | $0 |
| Steven Rosenberg | Yönetim kurulu üyesi | 05 Ocak 2016 A | 12.359 | 0 | 0 | $0 |
| Donald Press | Yönetim kurulu üyesi | 07 Ocak 2014 A | 43.970 | 0 | 0 | $0 |
| Moses Marx | Yönetim kurulu üyesi | 01 Aralık 2009 A | 107.532 | 0 | 0 | $0 |
| FRUTH JOHN D | Yönetim kurulu üyesi | 14 Ocak 2008 A | 6.500 | 0 | 0 | $0 |
| Edgar J Cummins | Yönetim kurulu üyesi | 27 Aralık 2005 S | 1.764 | 0 | 0 | $0 |
| COOPER COMPANIES INC | Yönetim kurulu üyesi | 01 Kasım 2004 A | · | 0 | 0 | $0 |
| Cynthia L Lucchese | · | 01 Nisan 2026 A | 12.767 | 1 | 0 | $149.963 |
| Daniel G Mcbride | · | 08 Ocak 2026 M | 69.352 | 0 | 0 | $0 |
| Albert G White III | · | 10 Aralık 2024 A | 245.072 | 1 | 0 | $808.000 |
| Andrew Sedgwick | · | 30 Eylül 2009 M | 0 | 0 | 0 | $0 |
| James M Welch | · | 27 Ekim 2005 A | 0 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 100 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| KMID · Virtus ETF Trust II | 2,96% | 18.688 NS | 31 Temmuz 2026 | N-PORT |
| EQTY · Valued Advisers Trust | 2,01% | 396.156 NS | 31 Temmuz 2026 | N-PORT |
| CVSM · Elevation Series Trust | 1,88% | 24.508 NS | 31 Temmuz 2026 | N-PORT |
| POWA · Invesco Exchange-Traded Self-Indexe… | 1,58% | 45.751 SH | 01 Ekim 2026 | Günlük |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,45% | 224.673 SH | 01 Ekim 2026 | Günlük |
| BSMQ · Invesco Exchange-Traded Self-Indexe… | 0,73% | 1.880.000 | 01 Ekim 2026 | Günlük |
| QQQJ · Invesco Exchange-Traded Fund Trust … | 0,56% | 115.163 SH | 01 Ekim 2026 | Günlük |
| FBCV · FIDELITY COVINGTON TRUST | 0,45% | 11.032 NS | 31 Temmuz 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 0,43% | 61.771 NS | 31 Temmuz 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,37% | 746.479 NS | 31 Temmuz 2026 | N-PORT |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,31% | 85.593 NS | 31 Temmuz 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,30% | 2.841.101 SH | 19 Ağustos 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,21% | 586.725 SH | 19 Ağustos 2026 | Günlük |
| BSMU · Invesco Exchange-Traded Self-Indexe… | 0,21% | 545.000 | 01 Ekim 2026 | Günlük |
| FHLC · FIDELITY COVINGTON TRUST | 0,20% | 92.713 NS | 31 Temmuz 2026 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0,18% | 3.081.517 SH | 01 Ekim 2026 | Günlük |
| SIZE · iShares Trust | 0,17% | 13.773 SH | 11 Eylül 2026 | Günlük |
| VB · VANGUARD INDEX FUNDS | 0,17% | 4.474.789 SH | 19 Ağustos 2026 | Günlük |
| IYH · iShares Trust | 0,17% | 114.003 SH | 11 Eylül 2026 | Günlük |
| CURE · Direxion Shares ETF Trust | 0,16% | 3.839 NS | 31 Temmuz 2026 | N-PORT |
| EUSA · iShares, Inc. | 0,14% | 50.851 SH | 11 Eylül 2026 | Günlük |
| ISCG · iShares Trust | 0,14% | 25.105 SH | 11 Eylül 2026 | Günlük |
| IXJ · iShares Trust | 0,13% | 102.346 SH | 11 Eylül 2026 | Günlük |
| DFSV · Dimensional ETF Trust | 0,13% | 142.024 NS | 31 Temmuz 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,11% | 7.195 NS | 31 Temmuz 2026 | N-PORT |
| EVUS · iShares Trust | 0,11% | 7.759 SH | 11 Eylül 2026 | Günlük |
| IWS · iShares Trust | 0,10% | 290.845 SH | 11 Eylül 2026 | Günlük |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,10% | 13.930 SH | 01 Ekim 2026 | Günlük |
| BSMT · Invesco Exchange-Traded Self-Indexe… | 0,10% | 270.000 | 01 Ekim 2026 | Günlük |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,09% | 19.651 NS | 31 Temmuz 2026 | N-PORT |
| IWR · iShares Trust | 0,08% | 796.790 SH | 11 Eylül 2026 | Günlük |
| BAB · Invesco Exchange-Traded Fund Trust … | 0,07% | 592.000 | 01 Ekim 2026 | Günlük |
| BSMR · Invesco Exchange-Traded Self-Indexe… | 0,06% | 215.000 | 01 Ekim 2026 | Günlük |
| VFVA · VANGUARD WELLINGTON FUND | 0,06% | 7.148 SH | 19 Ağustos 2026 | Günlük |
| XOEF · iShares Trust | 0,06% | 245 SH | 11 Eylül 2026 | Günlük |
| VLUE · iShares Trust | 0,06% | 105.585 SH | 11 Eylül 2026 | Günlük |
| DXUV · Dimensional ETF Trust | 0,05% | 3.837 NS | 31 Temmuz 2026 | N-PORT |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,05% | 44.755 SH | 19 Ağustos 2026 | Günlük |
| DFUV · Dimensional ETF Trust | 0,05% | 103.993 NS | 31 Temmuz 2026 | N-PORT |
| BSMS · Invesco Exchange-Traded Self-Indexe… | 0,05% | 155.000 | 01 Ekim 2026 | Günlük |
| CHRI · Global X Funds | 0,04% | 47 NS | 31 Temmuz 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,04% | 266.539 NS | 31 Temmuz 2026 | N-PORT |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,04% | 117.246 SH | 19 Ağustos 2026 | Günlük |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,04% | 6.125 SH | 01 Ekim 2026 | Günlük |
| IVE · iShares Trust | 0,04% | 325.198 SH | 11 Eylül 2026 | Günlük |
| IUSV · iShares Trust | 0,03% | 172.535 SH | 11 Eylül 2026 | Günlük |
| EGLE · Global X Funds | 0,03% | 10 NS | 31 Temmuz 2026 | N-PORT |
| GLBL · Pacer Funds Trust | 0,03% | 5 NS | 31 Temmuz 2026 | N-PORT |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,03% | 9.216 SH | 30 Eylül 2026 | Günlük |
| SUSL · iShares Trust | 0,03% | 6.864 SH | 11 Eylül 2026 | Günlük |
| DFAS · Dimensional ETF Trust | 0,03% | 63.415 NS | 31 Temmuz 2026 | N-PORT |
| DSI · iShares Trust | 0,03% | 29.689 SH | 11 Eylül 2026 | Günlük |
| DCOR · Dimensional ETF Trust | 0,03% | 13.489 NS | 31 Temmuz 2026 | N-PORT |
| IWD · iShares Trust | 0,03% | 434.725 SH | 11 Eylül 2026 | Günlük |
| TILT · FlexShares Trust | 0,03% | 8.374 NS | 31 Temmuz 2026 | N-PORT |
| XRMI · Global X Funds | 0,03% | 190 NS | 31 Temmuz 2026 | N-PORT |
| CRBN · iShares Trust | 0,03% | 5.717 SH | 11 Eylül 2026 | Günlük |
| XCLR · Global X Funds | 0,03% | 13 NS | 31 Temmuz 2026 | N-PORT |
| XYLG · Global X Funds | 0,03% | 225 NS | 31 Temmuz 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,03% | 43.268 NS | 31 Temmuz 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0,02% | 42.256 SH | 01 Ekim 2026 | Günlük |
| DFSU · Dimensional ETF Trust | 0,02% | 7.349 NS | 31 Temmuz 2026 | N-PORT |
| XYLD · Global X Funds | 0,02% | 9.976 NS | 31 Temmuz 2026 | N-PORT |
| BKLC · BNY Mellon ETF Trust | 0,02% | 16.763 NS | 31 Temmuz 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0,02% | 9.935 NS | 31 Temmuz 2026 | N-PORT |
| ACVF · ETF Opportunities Trust | 0,02% | 456 NS | 31 Temmuz 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,02% | 61.254 NS | 31 Temmuz 2026 | N-PORT |
| XTR · Global X Funds | 0,02% | 14 NS | 31 Temmuz 2026 | N-PORT |
| SPUU · Direxion Shares ETF Trust | 0,02% | 736 NS | 31 Temmuz 2026 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0,02% | 5.069.056 SH | 19 Ağustos 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | 0,02% | 6.191.667 SH | 19 Ağustos 2026 | Günlük |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,02% | 31.957 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,02% | 16.452 SH | 19 Ağustos 2026 | Günlük |
| ESGV · VANGUARD WORLD FUND | 0,02% | 43.944 SH | 19 Ağustos 2026 | Günlük |
| QDPL · Pacer Funds Trust | 0,02% | 4.676 NS | 31 Temmuz 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,02% | 33.939 SH | 01 Ekim 2026 | Günlük |
| TOPC · iShares Trust | 0,02% | 115 SH | 11 Eylül 2026 | Günlük |
| XVV · iShares Trust | 0,02% | 2.209 SH | 11 Eylül 2026 | Günlük |
| HCMT · Direxion Shares ETF Trust | 0,02% | 1.360 NS | 31 Temmuz 2026 | N-PORT |
| PBP · Invesco Exchange-Traded Fund Trust | 0,02% | 1.151 SH | 29 Eylül 2026 | Günlük |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0,02% | 33.649 SH | 01 Ekim 2026 | Günlük |
| SPXL · Direxion Shares ETF Trust | 0,02% | 15.254 NS | 31 Temmuz 2026 | N-PORT |
| IVV · iShares Trust | 0,02% | 2.459.565 SH | 11 Eylül 2026 | Günlük |
| IYY · iShares Trust | 0,02% | 8.448 SH | 11 Eylül 2026 | Günlük |
| IWV · iShares Trust | 0,02% | 55.887 SH | 11 Eylül 2026 | Günlük |
| IWB · iShares Trust | 0,02% | 134.163 SH | 11 Eylül 2026 | Günlük |
| VOXP · Advisors Series Trust | 0,02% | 12 NS | 31 Temmuz 2026 | N-PORT |
| ITOT · iShares Trust | 0,01% | 251.738 SH | 11 Eylül 2026 | Günlük |
| PHDG · Invesco Actively Managed Exchange-T… | 0,01% | 155 SH | 30 Eylül 2026 | Günlük |
| TOK · iShares Trust | 0,01% | 564 SH | 11 Eylül 2026 | Günlük |
| URTH · iShares, Inc. | 0,01% | 18.452 SH | 11 Eylül 2026 | Günlük |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,01% | 9.234 SH | 01 Ekim 2026 | Günlük |
| ACWI · iShares Trust | 0,01% | 65.230 SH | 11 Eylül 2026 | Günlük |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 173.475 SH | 19 Ağustos 2026 | Günlük |
| FTLS · First Trust Exchange-Traded Fund III | -0,15% | -50.276 NS | 31 Temmuz 2026 | N-PORT |
| BIV · VANGUARD BOND INDEX FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 14 Temmuz 2026 | Günlük |
| ISCB · iShares Trust | · | 8.790 SH | 11 Eylül 2026 | Günlük |
| ISCV · iShares Trust | · | 25.681 SH | 11 Eylül 2026 | Günlük |
COO Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
12 Aylık Fiyat Hedefi
14 analist · 2026-09-27Ortalama hedef $66.21 +16,3%
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| COO | $13.70B | 37.4 | 5.1% | 9.2% | 4.6% | 65.5% |
| MDLN | · | -4200.0 | 11.5% | 4.1% | 21.6% | 26.4% |
| SOLV | $13.75B | 8.9 | 0.86% | 18.7% | 35.8% | 53.5% |
| ALGN | $11.14B | 27.6 | 0.90% | 10.2% | 10.3% | 67.2% |
| LNTH | $4.30B | 19.5 | 0.50% | 15.2% | 20.7% | 61.1% |
| MMED | $3.71B | -10.2 | 14.2% | -10.7% | -9.3% | 54.2% |
| MMSI | $5.24B | 41.4 | 11.8% | 8.5% | 8.4% | 48.7% |
| HAE | $2.45B | 26.4 | -2.0% | 7.3% | 11.8% | 59.0% |
| QDEL | $1.99B | -1.8 | -1.9% | -41.4% | -48.0% | · |
| ICUI | $3.52B | 4755.7 | -6.3% | 0.03% | 0.03% | 36.8% |
Son Haberler Bu şirketten bahseden son manşetler
İşlem Sinyalleri Giriş fiyatı ve risk/ödül oranı ile son alım/satım sinyalleri
Şu anda açık sinyal yok — hiçbir kart dolu değil ve bu dürüstçe.
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.